Published in Gastroenterology Week, January 21st, 2008
Sequenom's leading edge high-throughput commercial platform for animal DNA screening and selection will allow MMI to scale up quickly, increasing MMI's ability to handle its rapidly increasing sample volumes following MMI's successful launches of DNA-based diagnostic products for both the livestock and companion animal markets. "The successful market acceptance of MMI's genomic products has accelerated our need...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.